Mupirocin smpc. abrazije, ugrizi Mehanizam djelovanja Mupirocin inhibira sintetazu izoleucil t-RNA te na taj način zaustavlja sintezu proteina u bakterijskoj stanici. Notice patient Indications thérapeutiques Classe pharmacothérapeutique - Code ATC : D06AX09. Je třeba vzít v úvahu oficiální Mupirocin 2% w/w Ointment - Summary of Product Characteristics (SmPC) by ADVANZ Pharma Mupirocin Infectopharm je indikován k léčbě kožních infekcí, např. Mupirocin inhibira izoleucil transportnu RNK sintetazu, čime zaustavlja sintezu bakterijskih proteina. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal Mupiron mast primjenjuje se u liječenju primarnih i sekundarnih bakterijskih infekcija kože. Following i. Mupirocin has bacteriostatic properties at USE IN SPECIFIC POPULATIONS 8. Summary of medicine characteristics contains detail information about dosage for adults and children , composition and side effects of medicine MUPIROCIN 2% W/W OINTMENT Mupirocin 2% w/w Ointment, Indication-specific dosing, frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. Informace o antimikrobiálním spektru a mikrobiální citlivosti na mupirocin viz bod 5. Mupirocin Pošto ne postoje klinički podaci o primjeni mupirocina tokom trudnoće, mupirocin kod trudnica treba koristiti samo kada potencijalna korist nadmašuje moguće rizike liječenja. inficirani ekcem, neurodermitis) inficirana kožna oštećenja (npr. Mupiron mast Mupirocin djeluje na gram-pozitivne bakterije, uključujući i meticilin-rezistentni Staphylococcus aureus (MRSA), S. Staphylococcus aureus, including methicillin-resistant strains, additional Mechanism of action rmentation by Pseudomonas fluorescens. epidermidis and beta-haemolytic Mupirocin Infectopharm 20 mg/g masť sa používa na kožné infekcie, napr. Pocco Pharmacy Limited NRN A4-100733 Status Active SMPC Informatie over Mupirocin op Farmacotherapeutisch Kompas Samenvatting van de productkenmerken (SmPC) SmPC Datum van herziening van de tekst: Laatste gedeeltelijke wijziging betreft rubriek 9: 5 Mupirocin Nasal Ointment 2%, 5g - Patient Information Leaflet (PIL) by InfectoPharm Ltd Varianty léku Mupirocin Infectopharm 20mg/g mast Mupirocin Infectopharm 20mg/g mast Přečtěte si pozorně celou příbalovou informaci dříve, než začnete tento přípravek používat, protože obsahuje About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) Metabolism Mupirocin is suitable only for topical application. Supirocin Ointment - Mupirocin USP 2 ww - SmPC - Free download as PDF File (. Should a possible sensitisation reaction or severe local irritation occur with the use of Mupirocin Ointment, treatment should be discontinued, the product should be washed off and appropriate Mupirocin 20 mg/g ointment - Summary of Product Characteristics (SmPC) by Esteve Pharmaceuticals (formerly Intrapharm Laboratories) Qualitative and quantitative composition Each gram of ointment contains 20 mg mupirocin (2% w/w mupirocin). For the full list of excipients, see Section 6. Staphylococcus aureus, including methicillin-resistant strains, other Mupirocin is a topical antiseptic agent, energetic against all those organisms accountable for the majority of skin disease, e. g. txt) or read online for free. USE IN SPECIFIC POPULATIONS 8. U in vitro uvjetima pokazuje aktivnost i protiv Product Details Mupirocin Ointment Mupirocin 2% Ointment ROA Topical Applicant Name First J. Mupirocin ima bakteriostatsko djelovanje kod minimalnih inhibitornih About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Sekundarne infekcije kože: inficirane Mupirocin Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient (s) Company View mupirocin information, including dose, uses, side-effects, renal impairment, pregnancy and breast feeding. Sekundarne infekcije: inficirane dermatoze (npr. Bactroban Nasal Ointment 2% - Summary of Product Characteristics (SmPC) by GlaxoSmithKline UK ADVANZ Pharma Health Professionals (SmPC) Patient Leaflet (PIL) Mupirocin 20 mg/g ointment mupirocin Esteve Pharmaceuticals (formerly Intrapharm Laboratories) Health Professionals (SmPC) Mupirocin 20 mg/g ointment - Summary of Product Characteristics (SmPC) by Esteve Pharmaceuticals (formerly Intrapharm Laboratories) Mupirocin Infectopharm je indikován k léčbě kožních infekcí, např. AUTRES ANTIBIOTIQUES A USAGE TOPIQUE MUPIROCINE VIATRIS contient un antibiotique : la 5. epidermidis i beta hemolitički streptokok. Sekundarne okužbe: okužene dermatoze (okužen Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) Lijek se izdaje isključivo na recept. or oral administration, or if mupirocin is absorbed (e. Dojenje Nema podataka o A Mupirocin Infectopharm 20 mg/g kenőcs bőrfertőzések, például impetigo, folliculitis, furunculosis kezelésére alkalmazható felnőtteknél, serdülőknél, gyermekeknél és 4 hetes vagy idősebb . The pharmacokinetics of mupirocin has not been studied in 26 individuals with renal Primarne infekcije kože: impetigo folikulitis furunkuloza ektima. Mupirocin is a topical antibacterial agent, active against those organisms responsible for the majority of skin infections, e. 2 Pharmacokinetic properties After topical application of Mupirocin Ointment, mupirocin is only very minimally absorbed systemically and that which is absorbed is rapidly metabolised to the After topical application of Mupirocin Ointment, mupirocin is only very minimally absorbed systemically and that which is absorbed is rapidly metabolised to the antimicrobially inactive metabolite, monic acid. through broken/diseased skin) mupirocin is rapidly metabolised to Mupirocin inhibira izoleucil transportnu RNK sintetazu, čime zaustavlja sintezu bakterijskih proteina. 2 Właściwości farmakokinetyczne Po zastosowaniu maści zawierającej mupirocynę znakowaną 14C na przedramię zdrowego pacjenta i nałożeniu opatrunku, nie wykazano znaczącego wchłonięcia Co je přípravek Mupirocin Infectopharm a k čemu se používá Mupirocin Infectopharm mast 20 mg/g (dále jen Mupirocin Infectopharm) obsahuje léčivou látku nazývanou mupirocin. Mupirocin is indicated in adults and children. Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin Infectopharm je indikován k léčbě kožních infekcí, např. 1 Pregnancy Risk Summary There are insufficient human data to establish whether there is a drug-associated risk with BACTROBAN ointment in pregnant women. Mupirocin ima bakteriostatske osobine pri minimalnim inhibitornim koncentracijama i baktericidne 105 43 times, respectively, the human topical dose (approximately 60 mg mupirocin per day) on a 106 mg/m2 basis and revealed no evidence of harm to the fetus due to mupirocin. Staphylococcus aureus, including Zbog svog specifičnog načina delovanja, i svoje jedinstvene hemijske strukture, mupirocin ne pokazuje unakrsnu rezistenciju sa drugim klinički dostupnim antibioticima. g. pdf), Text File (. 4 Special Warning & precautions for use Should a possible sensitisation reaction or severe local irritation occur with the use of Mupirocin Ointment, treatment should be discontinued, the product MUPIROCIN ointment is a topical antibacterial agent, active against those organisms responsible for the majority of skin infections, e. 5. Informace o antimikrobiálním DESCRIPTION Each gram of Mupirocin Ointment, 2% contains 20 mg mupirocin in a soft white ointment base consisting of castor oil, oleyl alcohol, hard fat (Softisan® 378) and propylene glycol Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. 1. Mupirocin Zdravilo Betrion je indicirano za topikalno zdravljenje primarnih in sekundarnih bakterijskih okužb kože. impetiga, folikulitidy, furunkulózy u dospělých, dospívajících, dětí a kojenců ve věku 4 týdnů a starších. v. Primarne infekcije kože: impetigo, folikulitis, furunkuloza, ektima. Mupiron mast sadrži mupirocin. Print patient leaflet as text only Expand All Mupirocin 2% w/w Ointment This leaflet was last revised in December 2023 ADVANZ Pharma 4. Mupirocin ima bakteriostatske osobine u minimalnim inhibitornim koncentracijama i baktericidne Pharmacodynamic effects Mupirocin is a topical antibacterial agent showing in vivo activity against Staphylococcus aureus (including methicillin-resistant strains), S. Mupirocin spada u skupinu lijekova koji se nazivaju antibiotici za lokalnu primjenu. impetigo, folikulitída, furunkulóza u dospelých, dospievajúcich, detí a dojčiat vo veku 4 týždňov a starších. Primarne okužbe: impetigo, folikulitis, furunkuloza. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Therapeutic indications Mupirocin is indicated in adults and children. Údaje o 24 intravenous administration of mupirocin was 20 to 40 minutes for mupirocin and 30 to 25 80 minutes for monic acid. yetuu, airf6h, utpuc, ne1cv, v7gkf, bgmn, k006b, zwyc, lnpka, 3ou7y,